每年出版 6 期
ISSN 打印: 1045-4403
ISSN 在线: 2162-6502
Indexed in
Role of Toll-Like Receptors in Hepatitis C Virus Pathogenesis and Treatment
摘要
Viral infections are rising every day, and viruses appear to be the most dangerous pathogens in the world. Hepatitis C virus (HCV) is accepted as one of the major destructive factors of promoting severe hepatic disorders by infecting more than 180 million individuals throughout the world. Chronic infection caused by HCV poses a serious global health emergency and appears to be a powerful threat to humanity. Almost 20 years have passed since the disclosure of HCV, but even now, treatment preferences remain limited. Humans are born with a rapid and nonspecific mechanism to prevent viral attacks through Toll-like receptors (TLRs), which are evolutionary conserved cellular activator proteins responsible for recognizing specific components present on penetrating microbes and viruses. Recent research efforts in TLR biology suggest that targeting the TLRs and their signaling pathways during HCV infection could contribute to novel therapies against HCV. The mobilization of TLRs boosts antiviral communication and integrates the development of long-lasting acquired immune responses to limit viral pathogenesis. Both activation and suppression of TLRs are necessary for the efficient treatment of HCV. For the proper management and eradication of HCV, novel drugs that target TLRs and their signaling pathway are needed. This review summarizes the role of TLR signaling in HCV infection and treatment.
-
Sghaier Ikram, Brochot Etienne, Loueslati Besma Y., Almawi Wassim Y., Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis, Reviews in Medical Virology, 29, 2, 2019. Crossref
-
Neag Maria Adriana, Mitre Andrei Otto, Catinean Adrian, Buzoianu Anca Dana, Overview of the microbiota in the gut-liver axis in viral B and C hepatitis, World Journal of Gastroenterology, 27, 43, 2021. Crossref
-
Yousaf Muhammad, Junaid Kashaf, Iqbal Muhammad Sarfaraz, Aslam Imran, Ahmad Sheraz, Aqeel Muhammad, Ashfaq Usman Ali, Khaliq Saba, Ghani Muhammad Usman, Waqar Nayyar, Analysis of dengue virus burden and serotypes pattern in Faisalabad, 2016–2017, Future Virology, 13, 4, 2018. Crossref
-
Iqbal Muhammad Sarfaraz, Ashfaq Usman Ali, Aslam Sadia, Khaliq Saba, Ghani Muhammad Usman, Batool Farzana, Analysis of polymorphism rs1990760 of IFIH1 gene and treatment outcomes in HCV infection, Future Virology, 13, 3, 2018. Crossref
-
Gao Yang, Nepal Narayan, Jin Shi-Zhu, Toll-like receptors and hepatitis C virus infection, Hepatobiliary & Pancreatic Diseases International, 20, 6, 2021. Crossref
-
Ghani Muhammad Usman, Haque Asma, Iqbal Muhammad Sarfaraz, Ashfaq Usman Ali, Mausood Muhammad Shareef, Qasim Muhammad, Jahan Shah, Shamsi Farwa Batool, Yousaf Muhammad, TGF-β1 rs1800469 gene polymorphism in the development of cirrhosis & hepatocellular carcinoma in Pakistani HCV patients, Future Virology, 14, 10, 2019. Crossref
-
Iqbal Muhammad Sarfaraz, Ashfaq Usman Ali, Khaliq Saba, Masoud Muhammad Shareef, Qasim Muhammad, Haque Asma, Ghani Muhammad Usman, Jahan Shah, Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment, Future Virology, 12, 12, 2017. Crossref
-
Sokolova T. M., Hepatitis C virus (Flaviviridae: Hepacivirus: Hepacivirus C): regulation of signaling reactions of innate immunity, Problems of Virology, 65, 6, 2021. Crossref